small molecule

ATRALIN

TRETINOIN

Loss of exclusivity—loss of exclusivity
CompanyDOW PHARMACEUTICAL SCIENCES

Drug detail

Brand nameATRALIN
Active ingredientTRETINOIN
Strength0.05%
Dosage formGEL
RouteTOPICAL
ModalitySmall molecule
FDA approvalJuly 2007
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.